The Recall Desk
HighFDA (Drugs)·D-1542-2014·Announced 2014-08-27

Baxter Recalls ProSol Amino Acid Injection Due to Particulate Matter

Baxter Healthcare is recalling 6,204 bags of ProSol Amino Acid Injection because a retention sample contained particulate matter. The product was distributed nationwide.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: The recall involves an intravenous drug with particulate matter, which poses a risk of harm, but the source text does not report any illnesses or injuries, fitting the 'High' severity criteria for risk-of-harm products without reported injury.

Plain-English summary

Baxter Healthcare Corporation is recalling 6,204 bags of ProSol (Amino Acid) Injection, 20%, 2000 mL VIAFLEX container bags. The product is identified by Lot # P306225 and has an expiration date of 08/14. The recall was initiated due to the identification of particulates in a retention sample.

The particulates were identified as a mixture of the amino acid leucine and inorganic material containing iron, silicone, and chlorine. The product is a prescription-only intravenous solution manufactured by Baxter Healthcare Corporation, Clinitec Nutrition Division, in Deerfield, IL.

The affected product was distributed nationwide. Patients and healthcare providers should stop using the recalled product and contact their healthcare provider for further instructions.

The recalled product

Product
PROSOL (VALINE, LYSINE, HISTIDINE, ISOLEUCINE, LEUCINE, PHENYLALANINE, THREONINE, METHIONINE, TRYPTOPHAN, ALANINE, GLYCINE, ARGININE, PROLINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID AND TYROSINE)
Brand
PROSOL
Affected units
6,204

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot #: P306225
  • Exp 08/14

Distribution

Distributed nationwide across the United States.